Soluble Prp
Soluble Prp - Related Videos
11:29
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
0 Views •
Cited by 7 •
2012
A new species of cellular prion protein (PrPC) has recently been identified in uninfected human brains using the methods described here. These methods can be used to isolate various PrP species, while some of them are also useful in isolating other misfolded protein aggregates from human brains.
06:36
PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
0 Views •
Cited by 35 •
2013
Implant-associated infection is a significant clinical complication. This study describes an approach using platelet-rich plasma (PRP) to prevent implant-associated infections, presents the protocol for preparing PRP with constant platelet concentration, and reports the newly identified antimicrobial properties of PRP and related protocols for examining such antimicrobial properties in vitro.
04:02
Solubility - Concepts
0 Views •
2020
Solubility Solubility describes how much of a solute can dissolve in a given volume of a specific solvent. Solubility is usually reported in terms of solute mass per solvent volume or solute mass per solvent mass. For example, the solubility of sodium chloride in water at room temperature is reported as 36 g per 100 mL of water. If solubility is reported in solute mass per solvent mass, the solvent mass will need to be converted to volume for further calculations. Solubility changes with...
04:01
Factors Affecting Solubility
0 Views •
2020
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide: This solubility equilibrium may be shifted left by the addition of either silver or iodide ions, resulting in...
03:07
Solubility Equilibria
0 Views •
2020
Solubility equilibria are established when the dissolution and precipitation of a solute species occur at equal rates. These equilibria underlie many natural and technological processes, ranging from tooth decay to water purification. An understanding of the factors affecting compound solubility is, therefore, essential to the effective management of these processes. This section applies previously introduced equilibrium concepts and tools to systems involving dissolution and precipitation. The...
FAQs
The critical event is a conformational shift in which cellular PrP acquires increased beta-sheet structure and becomes prone to aggregation. This altered form can promote conversion of additional PrP molecules, creating a molecular process that amplifies abnormal protein assembly. Studying the soluble starting state therefore helps researchers examine how pathogenic conversion begins before extensive aggregates develop.
The nonaggregated state provides a reference for understanding the normal behavior of cellular prion protein, PrPC, before misfolding occurs. Comparing this state with aggregation-prone forms can reveal which structural changes accompany disease-related conversion. That comparison is important because prion biology depends not only on the presence of PrP, but also on its conformation and assembly state.
Soluble PrP remains nonaggregated and water-compatible, whereas pathogenic prion-associated material is linked to misfolding and abnormal protein assembly. The distinction is biologically important because aggregation-prone conformations can promote further PrP conversion and are associated with neuronal injury. Researchers therefore examine both forms to separate potentially normal protein behavior from disease-related structural changes.
Researchers can use soluble PrP as a model for examining the molecular events that precede or accompany abnormal assembly. Structural analysis can focus on conformational change, increasing beta-sheet content, and the transition toward aggregation. These observations help connect protein-level changes with the early biology of transmissible spongiform encephalopathies and the later development of neuronal injury.
Detection research benefits from identifying differences between harmless soluble protein and pathogenic aggregates. Soluble PrP provides a comparison state against which abnormal assembly and aggregation-prone forms can be evaluated. This distinction may help clarify what a detection strategy must recognize, especially when the goal is to identify disease-associated protein changes rather than simply measure the presence of PrP.
Soluble PrP research supports therapeutic work by clarifying the conformational transition that precedes or contributes to abnormal aggregation. With that mechanism defined, investigators can study potential inhibitors designed to interfere with conversion or assembly. The broader objective is to reduce disease-associated protein accumulation and improve understanding of neuronal injury in transmissible spongiform encephalopathies.